Furthermore, administration of the TIM-3 antibody enhanced tumor formation in both murine and human melanomas with high and low immunogenicity in T-cell-deficient mice, which verified that antagonizing TIM-3 on melanoma cells can promote tumor growth. Here, HAVCR2 is linked to melanoma.